MEMPHIS, Tenn. and PULLMAN, Wash. – (January 28, 2016) – Pullman Regional Hospital, a critical access hospital in eastern Washington, recently acquired a new technology, Christie VeinViewer® Vision2, designed to make venipuncture much easier and to increase first stick success by up to 100%.

As part of the hospital’s focus on children’s health, the technology will be particularly helpful when drawing blood or inserting an IV on a child, which can be difficult for a number of reasons, including smaller veins, subcutaneous fat and greater elasticity of skin. However, the technology can be used on all patients, including adults who may have small or hard to find veins.

Stacey Aggabao, R.N., director of the Emergency Department, brought the technology to Pullman Regional Hospital because “it dramatically decreases the anxiety experienced by patients, parents and staff when drawing blood or starting an IV.”

Statistics show that first time “stick rates” have increased from 31 percent to 83 percent using the technology (Christie Clinical Operations 2008). Patient satisfaction scores also improve. In one study a hospital that started using VeinViewer more than doubled their patient satisfaction scores after one month.

VeinViewer Vision2 uses harmless near-infrared light to detect patient veins and then projects a real-time, high definition image of the vein pattern directly on the skin surface so providers can quickly find more options for accessing a patient’s veins. The non-invasive, hands-free device is designed to move around beds, and it is portable and on wheels so it can be moved throughout hospital departments, such as the Emergency Department, the Laboratory, and the Medical/Surgical units.

To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex please visit www.christiemed.com. For more information on Pullman Regional Hospital please visit our Facebook page.

About Christie Medical Holdings, Inc.

Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.

Follow us on Twitter @christiemed

Menu